Peptide-major histocompatibility complex complex on recipient cell

Peptide-major histocompatibility complex (MHC) complexes on recipient cells are membrane protein complexes formed when a **peptide antigen** is bound within the groove of an MHC molecule on the surface of a cell. These complexes are responsible for presenting antigenic peptides to T-cell receptors (TCRs) on T lymphocytes, a process essential for adaptive immunity[1][2][4][5][7]. MHC class I molecules present peptides to CD8+ cytotoxic T cells (found on all nucleated cells), enabling immune defense against viral infections and tumors[1][5][7]. MHC class II molecules present peptides to CD4+ helper T cells (found mainly on professional antigen-presenting cells such as dendritic cells, macrophages, and B cells), orchestrating broader immune responses[1][4][5][7]. These complexes are highly polymorphic, a feature critical for immune recognition diversity but also responsible for complications in transplant rejection and autoimmune disease risk[2][3][7]. They play a central role in the immune response to pathogens, tumor surveillance, autoimmunity, and allorecognition. Immunomodulatory therapies and diagnostic tools often target these complexes or downstream T cell responses[6].

Other names

Peptide-MHC complexPeptide-major histocompatibility complexAntigen-MHC complexMHC-peptide complex

Inhibition or modulation of T cell co-stimulation (by blocking antigen presentation or costimulatory signals) Induction of immune tolerance (with soluble peptide-MHC complexes or blocking agents)